Cart
sales@molnova.com
STAT3-IN-B9
CAS No. 825611-06-1
STAT3-IN-B9( STAT3 IN B9 | STAT3INB9 | B9 )
Catalog No. M27927 CAS No. 825611-06-1
STAT3-IN-B9 is an inhibitor of abnormal STAT3 activation and inhibits the proliferation of tumor cells including MDA-MB-468, MDA-MB-231, and DU145.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 500MG | 3348 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSTAT3-IN-B9
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTAT3-IN-B9 is an inhibitor of abnormal STAT3 activation and inhibits the proliferation of tumor cells including MDA-MB-468, MDA-MB-231, and DU145.
-
DescriptionSTAT3-IN-B9 is an inhibitor of abnormal STAT3 activation and inhibits the proliferation of tumor cells including MDA-MB-468, MDA-MB-231, and DU145.
-
In Vitro——
-
In Vivo——
-
SynonymsSTAT3 IN B9 | STAT3INB9 | B9
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorParasite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number825611-06-1
-
Formula Weight379.39
-
Molecular FormulaC20H13NO5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc1ccc(NS(=O)(=O)c2ccc3C(=O)c4ccccc4C(=O)c3c2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Luuc Keulen, et al. Bubble-Point Measurements and Modeling of Binary Mixtures of Linear Siloxanes. J Chem Eng Data. 2018;63:10.1021/acs.jced.8b00200.
molnova catalog
related products
-
JI069
JI069 (WAY-354189) is a potent STAT3 inhibitor that inhibits gp130 signaling by inducing dissociation between gp130 and JAK1.
-
Artesunate
Artesunate is a part of the artemisinin group of agents with an IC50 of < 5 μM for small cell lung carcinoma cell line H69.
-
Enzaplatovir
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
